within Pharmacolibrary.Drugs.ATC.C;

model C09AA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.24,
    Cl             = 0.00545,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.019,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C09AA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Perindopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension, heart failure, and stable coronary artery disease. It is an approved medication and is prescribed widely across the world to help lower blood pressure and protect heart function.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for perindopril reported in healthy adult subjects after single oral dosing.</p><h4>References</h4><ol><li><p>Macfadyen, RJ, et al., &amp; Reid, JL (1990). Perindopril. A review of its pharmacokinetics and clinical pharmacology. <i>Drugs</i> 39 Suppl 1 49–63. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199000391-00009&quot;>10.2165/00003495-199000391-00009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2407493/&quot;>https://pubmed.ncbi.nlm.nih.gov/2407493</a></p></li><li><p>Anderson, PJ, et al., &amp; Resplandy, G (1995). Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers. <i>British journal of clinical pharmacology</i> 39(4) 361–368. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1995.tb04463.x&quot;>10.1111/j.1365-2125.1995.tb04463.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7640141/&quot;>https://pubmed.ncbi.nlm.nih.gov/7640141</a></p></li><li><p>Devissaguet, JP, et al., &amp; Perret, L (1990). Pharmacokinetics of perindopril and its metabolites in healthy volunteers. <i>Fundamental &amp; clinical pharmacology</i> 4(2) 175–189. DOI:<a href=&quot;https://doi.org/10.1111/j.1472-8206.1990.tb00486.x&quot;>10.1111/j.1472-8206.1990.tb00486.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2351367/&quot;>https://pubmed.ncbi.nlm.nih.gov/2351367</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C09AA04;
